Issued Patents All Time
Showing 51–75 of 143 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 6369211 | MAGE-3 peptides presented by HLA class II molecules | Pascal Chaux, Vincent Stroobant, Pierre van der Bruggen | 2002-04-09 |
| 6353089 | Method for stimulating CTLs with peptides | Pierre van der Bruggen, Catia Traversari, Katharina Fleischauer | 2002-03-05 |
| 6339149 | Isolated nucleic acid molecules which encode tumor rejection antigens found in dage | Pierre Coulie, Hideyuki Ikeda | 2002-01-15 |
| 6328971 | MAGE-1 derived nona peptides, and compositions thereof | Pierre van der Bruggen | 2001-12-11 |
| 6323028 | Isolated peptides which comply with HLA-CW16 molecules and uses | Pierre van der Bruggen, Etienne DePlaen | 2001-11-27 |
| 6303756 | Tumor associated nucleic acids and uses therefor | Valerie Martelange, Charles De Smet | 2001-10-16 |
| 6297050 | Methods for treating subject with DAGE derived peptides | Pierre Coulie, Hideyuki Ikeda | 2001-10-02 |
| 6291430 | Mage-3 peptides presented by HLA class II molecules | Pascal Chaux, Vincent Stroobant, Pierre van der Bruggen, Kris Thielemans, Jurgen Kurthals | 2001-09-18 |
| 6284476 | Method of identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen/tyrosinase derived peptides, and methods for treating said individuals | Vincent Brichard, Aline Van Pel, Etienne De Plaen, Pierre Coulie, Jean-Christope Renauld +2 more | 2001-09-04 |
| 6271019 | Leukemia associated genes | Nicolas Van Baren, Pierre Coulie, Charles DeSmet, Sophie Lucas | 2001-08-07 |
| 6265215 | Isolated peptides which complex with HLA-Cw16 and uses thereof | Pierre van der Bruggen, Etienne DePlaen | 2001-07-24 |
| 6245333 | Isolated protein processed to peptides which form complexes with HLA molecules | Pierre Coulie | 2001-06-12 |
| 6245525 | Tumor associated nucleic acids and uses therefor | Valerie Martelange, Charles De Smet | 2001-06-12 |
| 6235525 | Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-3 and uses thereof | Benoit Van den Eynde, Pierre van der Bruggen | 2001-05-22 |
| 6221593 | Method for determining cancer by determining expression of MAGE-10 | Francis Brasseur, Donata Rimoldi, Etienne De Plaen | 2001-04-24 |
| 6222012 | Isolated nonapeptides presented by HLA molecules, and uses thereof | Pierre van der Bruggen, Etienne De Plaen, Christoph Lurquin, Catia Traversari, Beatrice Gaugler +2 more | 2001-04-24 |
| 6210886 | Method for diagnosing multiple myeloma by determining tumor rejection antigen precursors | Nicolas Van Baren, Francis Brasseur | 2001-04-03 |
| 6201111 | Methods for treating subjects with disorders characterized by expression of tumor rejection antigen precursors | Vincent Brichard, Aline Van Pel, Catia Traversari, Thomas Wolfel, Pierre Coulie +1 more | 2001-03-13 |
| 6194156 | Isolated nucleic acid molecules which encode TAGE molecules, and uses thereof | Pierre van der Bruggen | 2001-02-27 |
| 6171806 | Isolated peptide defined by SEQ ID NO: 17 and uses thereof | Jean Herman, Pierre Coulie, Pierre van der Bruggen | 2001-01-09 |
| 6165725 | Method for determining regression or progression of multiple myeloma | Nicolas Van Baren, Francis Brasseur | 2000-12-26 |
| 6147187 | Isolated tumor rejection antigen precursor mage-2 derived peptides and uses thereof | Cornelis Joseph Maria Melief, M. W. Visseren, W. Martin Kast, Pierre van der Bruggen | 2000-11-14 |
| 6130052 | Leukemia associated genes | Nicolas Van Baren, Pierre Coulie, Charles DeSmet, Sophie Lucas | 2000-10-10 |
| 6110694 | Methods for determining complexes of tumor rejection antigens and HLA-Cw*160/molecules | Pascale Boel, Claude Wildmann, Pierre van der Bruggen, Pierre Coulie, Jean-Christophe Renauld | 2000-08-29 |
| 6096520 | Brain glycogen phosphorylase cancer antigen | Vincent Brichard, Aline Van Pel, Fredric A. Gorin | 2000-08-01 |